178 related articles for article (PubMed ID: 2029505)
1. Chronic rejection in rat aortic allografts. An experimental model for transplant arteriosclerosis.
Mennander A; Tiisala S; Halttunen J; Yilmaz S; Paavonen T; Häyry P
Arterioscler Thromb; 1991; 11(3):671-80. PubMed ID: 2029505
[TBL] [Abstract][Full Text] [Related]
2. Triple drug immunosuppression significantly reduces aortic allograft arteriosclerosis in the rat.
Lemström KB; Räisänen-Sokolowski AK; Häyry PJ; Koskinen PK
Arterioscler Thromb Vasc Biol; 1996 Apr; 16(4):553-64. PubMed ID: 8624778
[TBL] [Abstract][Full Text] [Related]
3. Intimal thickening and medial necrosis in allograft arteriosclerosis (chronic rejection) are independently regulated.
Mennander A; Paavonen T; Häyry P
Arterioscler Thromb; 1993 Jul; 13(7):1019-25. PubMed ID: 8318503
[TBL] [Abstract][Full Text] [Related]
4. Transplant arteriosclerosis in a rat aortic model.
Isik FF; McDonald TO; Ferguson M; Yamanaka E; Gordon D
Am J Pathol; 1992 Nov; 141(5):1139-49. PubMed ID: 1443048
[TBL] [Abstract][Full Text] [Related]
5. Triple drug immunosuppression significantly reduces immune activation and allograft arteriosclerosis in cytomegalovirus-infected rat aortic allografts and induces early latency of viral infection.
Lemström KB; Bruning JH; Bruggeman CA; Lautenschlager IT; Häyry PJ
Am J Pathol; 1994 Jun; 144(6):1334-47. PubMed ID: 8203471
[TBL] [Abstract][Full Text] [Related]
6. Cytomegalovirus infection enhances mRNA expression of platelet-derived growth factor-BB and transforming growth factor-beta 1 in rat aortic allografts. Possible mechanism for cytomegalovirus-enhanced graft arteriosclerosis.
Lemström KB; Aho PT; Bruggeman CA; Häyry PJ
Arterioscler Thromb; 1994 Dec; 14(12):2043-52. PubMed ID: 7981194
[TBL] [Abstract][Full Text] [Related]
7. Rat aortic allografts: an experimental model for chronic transplant arteriosclerosis.
Häyry P; Mennander A; Tiisala S; Halttunen J; Yilmaz S; Paavonen T
Transplant Proc; 1991 Feb; 23(1 Pt 1):611-2. PubMed ID: 1990624
[No Abstract] [Full Text] [Related]
8. Chronic rejection in rat aortic allografts. IV. Effect of hypercholesterolemia in allograft arteriosclerosis.
Mennander A; Tikkanen MJ; Räisänen-Sokolowski A; Paavonen T; Ustinov J; Häyry P
J Heart Lung Transplant; 1993; 12(1 Pt 1):123-31; discussion 131-2. PubMed ID: 8443189
[TBL] [Abstract][Full Text] [Related]
9. Chronic rejection in the rat aortic allograft. V. Mechanism of the angiopeptin (BIM23014C) effect on the generation of allograft arteriosclerosis.
Mennander A; Räisänen A; Paavonen T; Häyry P
Transplantation; 1993 Jan; 55(1):124-8. PubMed ID: 8420036
[TBL] [Abstract][Full Text] [Related]
10. Chronic rejection of rat aortic allograft. II. Administration of cyclosporin induces accelerated allograft arteriosclerosis.
Mennander A; Tiisala S; Paavonen T; Halttunen J; Häyry P
Transpl Int; 1991 Sep; 4(3):173-9. PubMed ID: 1958283
[TBL] [Abstract][Full Text] [Related]
11. Cytomegalovirus antigen expression, endothelial cell proliferation, and intimal thickening in rat cardiac allografts after cytomegalovirus infection.
Lemström K; Koskinen P; Krogerus L; Daemen M; Bruggeman C; Häyry P
Circulation; 1995 Nov; 92(9):2594-604. PubMed ID: 7586362
[TBL] [Abstract][Full Text] [Related]
12. Acute cytomegalovirus infection induces a subendothelial inflammation (endothelialitis) in the allograft vascular wall. A possible linkage with enhanced allograft arteriosclerosis.
Koskinen P; Lemström K; Bruggeman C; Lautenschlager I; Häyry P
Am J Pathol; 1994 Jan; 144(1):41-50. PubMed ID: 8291611
[TBL] [Abstract][Full Text] [Related]
13. Partial inhibition of allograft arteriosclerosis (chronic rejection) by 15-deoxyspergualin.
Räisänen-Sokolowski A; Yilmaz S; Tufveson G; Häyry P
Transplantation; 1994 Jun; 57(12):1772-7. PubMed ID: 8016883
[TBL] [Abstract][Full Text] [Related]
14. Endothelial loss and regeneration in a model of transplant arteriosclerosis.
Gohra H; McDonald TO; Verrier ED; Aziz S
Transplantation; 1995 Jul; 60(1):96-102. PubMed ID: 7624951
[TBL] [Abstract][Full Text] [Related]
15. Reversibility of allograft arteriosclerosis after retransplantation to donor strain.
Mennander A; Häyry P
Transplantation; 1996 Aug; 62(4):526-9. PubMed ID: 8781620
[TBL] [Abstract][Full Text] [Related]
16. Suppression of acute rejection prevents graft arteriosclerosis after allogeneic aorta transplantation in the rat.
Geerling RA; de Bruin RW; Scheringa M; Bonthuis F; Jeekel J; Ijzermans JN; Marquet RL
Transplantation; 1994 Dec; 58(11):1258-63. PubMed ID: 7992371
[TBL] [Abstract][Full Text] [Related]
17. Cytomegalovirus infection-enhanced allograft arteriosclerosis is prevented by DHPG prophylaxis in the rat.
Lemström KB; Bruning JH; Bruggeman CA; Koskinen PK; Aho PT; Yilmaz S; Lautenschlager IT; Häyry PJ
Circulation; 1994 Oct; 90(4):1969-78. PubMed ID: 7923687
[TBL] [Abstract][Full Text] [Related]
18. Recipient cells form the intimal proliferative lesion in the rat aortic model of allograft arteriosclerosis.
Johnson P; Carpenter M; Hirsch G; Lee T
Am J Transplant; 2002 Mar; 2(3):207-14. PubMed ID: 12096782
[TBL] [Abstract][Full Text] [Related]
19. Effect of sarpogrelate hydrochloride, a 5-hydroxytryptamine2 receptor antagonist, on allograft arteriosclerosis after aortic transplantation in rats.
Watada S; Harada H; Matsubara K; Obara H; Matsumoto K; Ando N; Kitagawa Y
Transpl Immunol; 2013 Dec; 29(1-4):162-6. PubMed ID: 23851153
[TBL] [Abstract][Full Text] [Related]
20. Experimental graft arteriosclerosis. I. The Lewis-to-F-344 allograft model.
Adams DH; Tilney NL; Collins JJ; Karnovsky MJ
Transplantation; 1992 May; 53(5):1115-9. PubMed ID: 1585476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
